DNA Capital is the famous VC, which was founded in 2013.
The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Clover Health, Cambridge Epigenetix, Feegow Clinic. Among the most popular fund investment industries, there are Cloud Computing, Biotechnology. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The typical startup value when the investment from DNA Capital is 500 millions - 1 billion dollars. The important activity for fund was in 2018. Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the DNA Capital, startups are often financed by Sequoia Capital, SOSV, First Round Capital. The meaningful sponsors for the fund in investment in the same round are GV, Y Combinator, Varian Medical Systems. In the next rounds fund is usually obtained by Greenoaks Capital, Asset Management Ventures (AMV).
The overall number of key employees were 8.
Funds with similar focus
|9W Capital Management||-|
|ABC International||China, Hong Kong, Hong Kong Island|
|Beam Suntory||Deerfield, Illinois, United States|
|DJ Capital||China, Shanghai|
|GOUFUYUAN VC||China, Guangdong, Shenzhen|
|Hang Lung Group||-|
|Linkage Biosciences||California, San Francisco, United States|
|Neuron.VC||California, Redwood City, United States|
|Newell Brands Inc.||Atlanta, Georgia, United States|
|Park Vale Capital||England, London, United Kingdom|
|Shanghai Xiangzhong Investment||China, Shanghai|
|SHLOMO ELIA INVESTMENTS LTD||-|
|Unicore Technology Company||-|
|Yike Zhengrun Investment Group||-|
|ZD Capital||China, Guangdong, Guangzhou|
|$190M||01 Apr 2022||Sao Paulo, São Paulo, Brazil|
|$8M||30 Mar 2022||Minneapolis, Minnesota, United States|
|$30M||10 Mar 2022||Minneapolis, Minnesota, United States|
|$190M||30 Nov 2021||São Paulo, São Paulo, Brazil|
|$19M||29 Oct 2021||São Paulo, São Paulo, Brazil|
|$10M||15 Sep 2021||Indianapolis, Indiana, United States|
|$250K||01 Jul 2021||Dakar, Dakar, Senegal|
|$57M||16 Jun 2021||São Paulo, São Paulo, Brazil|
|$20M||13 Apr 2021||Rio de Janeiro, Rio de Janeiro, Brazil|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.